Publication | Open Access

Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance)

Ncctg N0871OncologyMedicinePathologyCancer GenomicsCancer TreatmentCancer GeneticsGene ExpressionCancer BiologyRadiation OncologyCancer ResearchIdentifies Responsive Patients